Company Filing History:
Years Active: 2023-2025
Title: The Innovative Contributions of Valentine Yeung
Introduction
Valentine Yeung is a notable inventor based in Belmont, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 2 patents to his name, Yeung's work focuses on enhancing immune responses to treat various diseases.
Latest Patents
Yeung's latest patents include the development of Anti-CD96 antibodies and methods of use thereof. This patent provides binding proteins, such as antibodies and antigen-binding fragments, which specifically bind to the human CD96 receptor protein (hu-CD96). These antibodies are capable of decreasing, inhibiting, and fully blocking immune regulatory effects mediated by hu-CD96. The patent also outlines methods for using these antibodies to treat diseases and conditions that respond to the modulation of immune regulatory functions mediated by CD96 binding to CD155. This includes addressing effects arising from CD96 interactions with CD226 and TIGIT.
Career Highlights
Valentine Yeung is currently employed at 23andMe, Inc., where he continues to innovate in the field of biotechnology. His work at the company reflects his commitment to advancing medical science through the development of novel therapeutic solutions.
Collaborations
Yeung collaborates with talented individuals such as Yu Chen and Chingwei Vivian Lee, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Valentine Yeung's contributions to biotechnology, particularly through his patents on Anti-CD96 antibodies, highlight his role as a significant inventor in the field. His work not only advances scientific understanding but also holds the potential to improve therapeutic strategies for various diseases.